2026 Q2 Portfolio Activity
In 2026 Q2, Omega Fund Management, LLC maintained a portfolio of 11 distinct positions. The most significant new addition was Odyssey Therapeutics Inc., now representing 0.03% of the total fund value. Conversely, Omega Fund Management, LLC completely exited their position in Replimune Group.
Position History
hover any row below to update
Loading…
Total Positions
11
Quarter
2026 Q2
Top Holding
BCAX (29.1%)
Top 10 Concentration
100.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-11 of 11
Omega Fund Management, LLC Full Holdings List — 2026 Q2
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
BCAX
Bicara Therapeu...
|
Healthcare | 29.14% | 29.16% |
#1
Prev: #1
|
6.0 |
—
|
-570,000 | -23.8% |
P
S
|
1,822,150 | $54,099,634 | 2024 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
NUVB
Nuvation Bio In...
|
Healthcare | 24.72% | 21.25% |
#2
Prev: #2
|
6.5 |
—
|
no change | no change |
P
S
|
8,081,089 | $45,900,586 | 2021 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
KMTS
Kestra Med Tech...
|
Healthcare | 14.00% | 12.49% |
#3
1
Prev: #4
|
6.0 |
—
|
no change | no change |
P
S
|
1,022,149 | $26,003,471 | 2025 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BBOT
BridgeBio Oncol...
|
Healthcare | 13.50% | 18.05% |
#4
1
Prev: #3
|
5.5 |
—
|
no change | no change |
P
S
|
3,289,661 | $25,067,217 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BBNX
Beta Bionics In...
|
Healthcare | 11.11% | 8.08% |
#5
Prev: #5
|
5.5 |
—
|
no change | no change |
P
S
|
1,316,183 | $20,624,588 | 2025 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ALMS
Alumis Inc.
|
Healthcare | 3.66% | 3.26% |
#6
1
Prev: #7
|
2.5 |
—
|
no change | no change |
P
S
|
241,255 | $6,788,916 | 2024 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
SANA
Sana Biotechnol...
|
Healthcare | 1.59% | 1.49% |
#7
1
Prev: #8
|
1.6 |
—
|
no change | no change |
P
S
|
843,750 | $2,944,688 | 2021 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
IMA
ImageneBio, Inc...
|
Healthcare | 1.45% | 1.40% |
#8
1
Prev: #9
|
1.6 |
—
|
no change | no change |
P
S
|
455,361 | $2,686,630 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ENGN
enGene Holdings...
|
Healthcare | 0.82% | 3.66% |
#9
3
Prev: #6
|
1.3 |
—
|
no change | no change |
P
S
|
876,357 | $1,516,098 | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
N/A
Odyssey Therape...
|
|
Unknown | 0.03% | — |
#10
Prev: #—
|
3.5 |
—
|
2,893 | — |
NEW
|
2,893 | $54,128 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
REPL
Replimune Group
|
Healthcare | 0.00% | 1.17% |
Sold All 😨
(Was: #10) |
0.0 |
—
|
-248,672 | -100.0% |
CLOSED
|
— | $— | 2018 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 |
Showing 1-11 of 11 holdings